SecBot SecBot
SECBOTREPLAY Home › Report › PASW

PASW · Patent purchase $2.3M

Ping An Biomedical Co., Ltd. · 6-K filed Nov 5, 2026 at 08:45 ET

At the news

NEUTRALIMPACT 3/10

6-K filed Nov 5, 2026 at 08:45 ET

Ping An Biomedical entered a definitive agreement to acquire three tumor cell-related medical technology patents from Future Biotechnology Group for $2.3 million. The acquisition is positioned as a long-term capacity-building move, not a near-term revenue driver, and the company continues to advance negotiations for a strategic investment in the seller.

  • Definitive purchase agreement for three tumor cell-related patents at $2.3 million
  • Patents cover oncology diagnosis/treatment, cell detection/bioengineering, biomarker/DNA probe technologies
  • Company states the acquisition is not a near-term revenue driver but a capacity-building move
  • Separately, negotiations continue for a proposed strategic investment in Future Biotechnology Group

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access